CD24 and colorectal adenocarcinoma: Some studies suggest that loss of CD24 expression is associated with poorer outcomes [49], while others suggest that CD24 is a good prognosis marker in CRC, being down-regulated in stage IV colorectal adenocarcinoma [46].